BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15082225)

  • 1. Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice.
    Gruss M; Braun K
    Neurochem Int; 2004 Jul; 45(1):81-8. PubMed ID: 15082225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome.
    Gruss M; Braun K
    Neural Plast; 2001; 8(4):285-98. PubMed ID: 12018775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex- and region-specific alterations of basal amino acid and monoamine metabolism in the brain of aquaporin-4 knockout mice.
    Fan Y; Zhang J; Sun XL; Gao L; Zeng XN; Ding JH; Cao C; Niu L; Hu G
    J Neurosci Res; 2005 Nov; 82(4):458-64. PubMed ID: 16237719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation.
    Qin M; Kang J; Smith CB
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15758-63. PubMed ID: 12427968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Fragile X syndrome and an FMR1 knockout mouse model on forebrain neuronal cell biology.
    Churchill JD; Beckel-Mitchener A; Weiler IJ; Greenough WT
    Microsc Res Tech; 2002 May; 57(3):156-8. PubMed ID: 12112451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency.
    Li J; Pelletier MR; Perez Velazquez JL; Carlen PL
    Mol Cell Neurosci; 2002 Feb; 19(2):138-51. PubMed ID: 11860268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
    Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
    Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome.
    el Bekay R; Romero-Zerbo Y; Decara J; Sanchez-Salido L; Del Arco-Herrera I; Rodríguez-de Fonseca F; de Diego-Otero Y
    Eur J Neurosci; 2007 Dec; 26(11):3169-80. PubMed ID: 18005058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse.
    El Idrissi A; Ding XH; Scalia J; Trenkner E; Brown WT; Dobkin C
    Neurosci Lett; 2005 Apr; 377(3):141-6. PubMed ID: 15755515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X syndrome, the Fragile X related proteins, and animal models.
    Hoogeveen AT; Willemsen R; Oostra BA
    Microsc Res Tech; 2002 May; 57(3):148-55. PubMed ID: 12112450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rgs4 mRNA expression is decreased in the brain of Fmr1 knockout mouse.
    Tervonen T; Akerman K; Oostra BA; Castrén M
    Brain Res Mol Brain Res; 2005 Jan; 133(1):162-5. PubMed ID: 15661377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.
    Yan QJ; Asafo-Adjei PK; Arnold HM; Brown RE; Bauchwitz RP
    Genes Brain Behav; 2004 Dec; 3(6):337-59. PubMed ID: 15544577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mouse model for the fragile X syndrome.
    Kooy RF; D'Hooge R; Reyniers E; Bakker CE; Nagels G; De Boulle K; Storm K; Clincke G; De Deyn PP; Oostra BA; Willems PJ
    Am J Med Genet; 1996 Aug; 64(2):241-5. PubMed ID: 8844056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term potentiation in the hippocampus of fragile X knockout mice.
    Godfraind JM; Reyniers E; De Boulle K; D'Hooge R; De Deyn PP; Bakker CE; Oostra BA; Kooy RF; Willems PJ
    Am J Med Genet; 1996 Aug; 64(2):246-51. PubMed ID: 8844057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fragile X syndrome: a model of gene-brain-behaviour relationships].
    Hagerman RJ; Hagerman PJ
    Rev Neurol; 2001 Oct; 33 Suppl 1():S51-7. PubMed ID: 12447820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered mossy fiber distributions in adult Fmr1 (FVB) knockout mice.
    Ivanco TL; Greenough WT
    Hippocampus; 2002; 12(1):47-54. PubMed ID: 11918288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
    Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
    J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fragile X syndrome: from molecular genetics to neurobiology.
    Willemsen R; Oostra BA; Bassell GJ; Dictenberg J
    Ment Retard Dev Disabil Res Rev; 2004; 10(1):60-7. PubMed ID: 14994290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo.
    Mientjes EJ; Nieuwenhuizen I; Kirkpatrick L; Zu T; Hoogeveen-Westerveld M; Severijnen L; Rifé M; Willemsen R; Nelson DL; Oostra BA
    Neurobiol Dis; 2006 Mar; 21(3):549-55. PubMed ID: 16257225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress induced changes in cortical and hypothalamic c-fos expression are altered in fragile X mutant mice.
    Lauterborn JC
    Brain Res Mol Brain Res; 2004 Nov; 131(1-2):101-9. PubMed ID: 15530658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.